Article
AbbVie scopes out $60M upfront investment in glaucoma devicemaker, plus $475M buyout option
Rating:
0.0
Views:
81
Likes:
1
Library:
1
AbbVie has set its sights on a new medical device partnership to expand the scope of its existing eye-care portfolio. | AbbVie has set its sights on a new medical device partnership to expand the scope of its existing eye care portfolio.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value